China's health program to support financial burden on patients
A new round of China's bulk buy program for drugs will include 385 products from 234 companies in an effort to further reduce the financial burden of patients, according to the National Healthcare Security Administration. The bulk buy program sees drug manufacturers cutting prices of generic drugs for large-volume contracts with public hospitals. According to preliminary bidding results released on Friday, a total of 62 types of medicines have won bids, covering a number of fields including high blood pressure, diabetes, cancer, cardiovascular diseases, infectious illnesses and mental health. China has so far launched ten rounds of centralized procurement programs for drugs since 2018, involving 435 types of medicines, according to the administration.
Discover Related
Branded medicines over generic: How the market is putting patients in a bind
How Trump’s tariffs could upend pharma’s overseas tax strategy
Cost of living woes fuelling fake medicine demand in Nigeria
China further opens its door to attract FDI
China beats global average in tackling TB cases
Sino Biopharm targets 30 innovative products by 2027
Agents for chemotherapy increasingly unavailable; Dutch hospitals concerned
Behind America's decades-long fight to dismantle the PBS
PBS medication to cost no more than $25 under Labor re-election pitch
Patients scramble as cheaper obesity drug alternatives disappear
India produces key drug ingredients under PLI scheme to cut China dependence
Over 90% of China's village clinics covered by basic medical insurance
At least one Jan Aushadhi Kendra to be set up near every hospital: Delhi CM
Chinese company's drug beats world's biggest-selling medicine: media
Medicare spending on diabetes drugs surged over 5 years, US report shows
Authorities crack down on pharma firms amid ban on addictive opioids
Higher dose and even cheaper: New vials of popular weight-loss drug released
Tech, auto, medicines: who will pay Donald Trump's tariffs?
‘Pharmacy of the world’ pins hope on Modi govt to avert Trump tariff crisis
‘Pharmacy of the world’ pins hope on Modi govt to avert Trump tariff crisis
What a $2 million per dose gene therapy reveals about drug pricing
Health insurers ditch cover for two breast cancer drugs
It’s not just AI. China’s medicines are surprising the world, too
A taste of their own medicine: Reciprocal tariffs will hurt US healthcare and how
Thinking of buying obesity drugs online? Read this first
India is cracking down on fake drugs—retailers and wholesalers could pay the price
WHO launches plan for free child cancer medicines
New drug for type 2 diabetes to be offered